TuHURA Biosciences, Inc.
HURA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001498382
No open-market purchases or sales by TuHURA Biosciences, Inc. insiders were filed in the last 90 days; 89 institutions reported holding it in 13F filings for Q2 2026, worth $21.0M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by TuHURA Biosciences, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for TuHURA Biosciences, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Bianco James A. | Chief Executive Officer | 2,173,307 | May 29, 2026 | 3 |
| Hoffman Robert | Director | 68,902 | Feb 17, 2026 | 1 |
| Manuso James S J | Director | – | Feb 17, 2026 | 1 |
| Ng George K | Director | – | Feb 17, 2026 | 1 |
| List Alan | Director | – | Feb 17, 2026 | 1 |
| Tendler Craig | Director | – | Feb 17, 2026 | 1 |
| Dearborn Dan | Chief Financial Officer | – | Jan 8, 2026 | 2 |
| Yamashita Dennis | Chief Scientific Officer | – | Oct 22, 2024 | 0 |
| Seymour Tamara A | Director | – | Sep 1, 2023 | 0 |
| Brown Dennis M | Chief Scientific Officer | 5,302 | Sep 1, 2023 | 0 |
| Toth Robert Joseph Jr | Director | – | Sep 1, 2023 | 0 |
| Johnson Laura L. | Director | 3,000 | Sep 1, 2023 | 0 |
| Praill Anthony Scott | Chief Financial Officer | 277,273 | Aug 3, 2022 | 0 |
| Zarrabian Saiid | Head of Strategic Partnerships | 55,500 | Dec 8, 2021 | 0 |
| Murphy Keith | Director | – | Sep 22, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 17, 2022 (view filing)4:00 PM ET | Feb 15 | 2 days | Hoffman RobertPresident and CEO | PPurchase | +55.0K | $0.469 | +$25.8K | New position55.0K after | |
| Dec 9, 2021 (view filing) | Dec 8 | 1 day | Praill Anthony ScottChief Financial Officer | PPurchase | +28.7K | $0.68 | +$19.5K | +338.2%37.2K after | |
| Dec 8, 2021 (view filing) | Dec 6-7 | 2 days | Zarrabian SaiidHead of Strategic Partnerships | PPurchase | +50.0K | $0.6281 | +$31.4K | +909.1%55.5K after | 2 lots |
| Nov 24, 2021 (view filing) | Nov 22 | 2 days | Johnson Laura L.Director | PPurchase | +3.00K | $0.74 | +$2.22K | New position3.00K after |